Which has the lower trailing P/E, EW or IDXX?

IDXX has the lower trailing P/E: EW trades at 49.59 and IDXX at 36.77. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, EW or IDXX?

Over the past five years, IDXX grew revenue faster — EW at a 5.75% CAGR versus IDXX at 8.37%.

Is EW or IDXX more profitable?

IDXX runs the higher net margin — EW at 15.43% versus IDXX at 25.03%.

How have EW and IDXX total returns compared?

Over the past 10 years, EW delivered 8.24% and IDXX delivered 16.45% annualized total return. Past performance doesn't predict future results.

Edwards Lifesciences Corporation (EW) vs IDEXX Laboratories, Inc. (IDXX)

A side-by-side comparison of Edwards Lifesciences Corporation and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Edwards Lifesciences Corporation

$49.69B

$86.29HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

IDXX

IDEXX Laboratories, Inc.

$40.96B

$519.26HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — EW vs IDXX

growth of $100 · dividends reinvested · last 10y

EW +116.4% (+8.0%/yr)IDXX +342.9% (+16.0%/yr)IDXX compounded faster over this window

EW IDXX

EW vs IDXX: by the numbers

•EW is the larger company ($49.69B vs $40.96B market cap).
•IDXX trades at the lower trailing earnings multiple (36.77 vs 49.59 P/E), one valuation lens rather than an overall verdict.
•IDXX converts more revenue to profit (25.03% vs 15.43% net margin).
•IDXX grew revenue faster over the past five years (8.37% vs 5.75% CAGR).

Metrics side by side

Valuation

Metric	EW	IDXX
P/E ratio	49.59	36.77
Forward P/E	28.75	35.15
P/S ratio	7.63	9.00
P/B ratio	4.68	25.40
EV / EBITDA	23.80	25.96
FCF yield	2.89%	3.05%

Profitability

Metric	EW	IDXX
Gross margin	77.98%	62.45%
Operating margin	28.09%	32.03%
Net margin	15.43%	25.03%
ROE	9.46%	70.67%
ROIC	10.22%	41.33%

Growth (annualized)

Metric	EW	IDXX
Revenue CAGR (5Y)	5.75%	8.37%
EPS CAGR (5Y)	6.87%	14.07%
FCF CAGR (5Y)	6.41%	12.49%
Total return CAGR (5Y)	-6.94%	-5.83%

Frequently asked

Which has the lower trailing P/E, EW or IDXX?: IDXX has the lower trailing P/E: EW trades at 49.59 and IDXX at 36.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, EW or IDXX?: Over the past five years, IDXX grew revenue faster — EW at a 5.75% CAGR versus IDXX at 8.37%.
Is EW or IDXX more profitable?: IDXX runs the higher net margin — EW at 15.43% versus IDXX at 25.03%.
How have EW and IDXX total returns compared?: Over the past 10 years, EW delivered 8.24% and IDXX delivered 16.45% annualized total return. Past performance doesn't predict future results.

Go deeper

Full EW analysis Full IDXX analysis Interactive comparison tool

Dig into the metrics

Edwards Lifesciences P/E ratio IDEXX Laboratories P/E ratio Edwards Lifesciences ROE IDEXX Laboratories ROE Edwards Lifesciences operating margin IDEXX Laboratories operating margin Edwards Lifesciences revenue growth IDEXX Laboratories revenue growth Edwards Lifesciences free cash flow IDEXX Laboratories free cash flow

Edwards Lifesciences & IDEXX Laboratories appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.